Quince Therapeutics
QNCX
QNCX
44 hedge funds and large institutions have $7.84M invested in Quince Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$140K | |
| 2 | +$95.6K | |
| 3 | +$46K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$44.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.9K |
Top Sellers
| 1 | -$293K | |
| 2 | -$59.2K | |
| 3 | -$23K | |
| 4 |
SB
Strategic Blueprint
Atlanta,
Georgia
|
-$13.7K |
| 5 |
LBC
Lawrence B. Cohen
|
-$12.5K |